Bamco Inc Emergent Bio Solutions Inc. Transaction History

Bamco Inc

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$56.61 - $80.46 $12.7 Million - $18.1 Million	-225,000 Closed	0 $0
Q1 2021 May 19, 2021	BUY	$86.23 - $125.19 $3.45 Million - $5.01 Million	40,000 Added 21.62%	225,000 $20.9 Million
Q4 2020 Feb 12, 2021	SELL	$79.17 - $111.47 $1.98 Million - $2.79 Million	-25,000 Reduced 11.9%	185,000 $16.6 Million
Q3 2020 Nov 13, 2020	SELL	$81.91 - $134.94 $2.05 Million - $3.37 Million	-25,000 Reduced 10.64%	210,000 $21.7 Million
Q2 2020 Aug 14, 2020	SELL	$54.33 - $89.52 $2.99 Million - $4.92 Million	-55,000 Reduced 18.97%	235,000 $18.6 Million

Q3 2019 Nov 14, 2019	BUY	$40.6 - $57.2 $3.86 Million - $5.43 Million	95,000 Added 48.72%	290,000 $15.2 Million
Q2 2019 Aug 15, 2019	BUY	$39.92 - $53.86 $3.47 Million - $4.69 Million	87,000 Added 80.56%	195,000 $9.42 Million
Q1 2019 May 15, 2019	BUY	$48.23 - $66.16 $2.32 Million - $3.18 Million	48,000 Added 80.0%	108,000 $5.46 Million
Q2 2018 Aug 14, 2018	BUY	$48.33 - $55.64 $724,950 - $834,600	15,000 Added 33.33%	60,000 $3.03 Million
Q4 2017 Feb 14, 2018	BUY	$37.77 - $47.75 $1.7 Million - $2.15 Million	45,000	45,000 $2.09 Million

137

35.6M

78.7K

75.1K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $405M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of Bamco Inc , based on Form 13F filings with the SEC.

Stay updated on Bamco Inc with notifications on news.